argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
869.83
+15.18 (1.78%)
At close: Nov 10, 2025, 4:00 PM EST
880.60
+10.77 (1.24%)
After-hours: Nov 10, 2025, 6:59 PM EST
argenx SE Market Cap
argenx SE has a market cap or net worth of $52.69 billion as of November 10, 2025. Its market cap has increased by 59.87% in one year.
Market Cap
52.69B
Enterprise Value
48.86B
1-Year Change
59.87%
Ranking
Category
Stock Price
$869.83
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $52.69B, an increase of 8,425.46%. That is a compound annual growth rate of 68.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 53.09B | 44.36% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 865.51B |
| Johnson & Johnson | 453.94B |
| AbbVie | 386.54B |
| UnitedHealth Group | 291.30B |
| AstraZeneca | 267.87B |
| Novartis AG | 243.29B |
| Abbott Laboratories | 218.91B |
| Thermo Fisher Scientific | 216.54B |